BRPI0507747A - medicamento com base em planta para o tratamento da hepatite c - Google Patents

medicamento com base em planta para o tratamento da hepatite c

Info

Publication number
BRPI0507747A
BRPI0507747A BRPI0507747-8A BRPI0507747A BRPI0507747A BR PI0507747 A BRPI0507747 A BR PI0507747A BR PI0507747 A BRPI0507747 A BR PI0507747A BR PI0507747 A BRPI0507747 A BR PI0507747A
Authority
BR
Brazil
Prior art keywords
hepatitis
botanical
treatment
plant
botanical drug
Prior art date
Application number
BRPI0507747-8A
Other languages
English (en)
Inventor
Shouming Zhong
Hongwen Yu
Original Assignee
Phynova Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phynova Ltd filed Critical Phynova Ltd
Publication of BRPI0507747A publication Critical patent/BRPI0507747A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/79—Schisandraceae (Schisandra family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

MEDICAMENTO COM BASE EM PLANTA PARA O TRATAMENTO DA HEPATITE C A invenção atual refere-se a uma droga botânica ou suplemento dietético para uso no tratamento de pacientes sofrendo de infecção por vírus de hepatite C. Mais especialmente, ela refere-se a uma droga botânica consistindo essencialmente de quatro substâncias de drogas botânicas, opcionalmente formuladas com excipientes, para uso no alívio dos sintomas de hepatite, especialmente de hepatite C crónica, e/ou ainda a inibição da atividade do vírus que causa a hepatite C. As matérias-primas botânicas, as substâncias de drogas botânicas ou os ingredientes botânicos utilizados, são cada um deles das epécies do gênero: (a) Silybum; (b) Astragalus ou Hedysarum; (c) Salvia; e (d) Schisandra.
BRPI0507747-8A 2004-02-19 2005-02-17 medicamento com base em planta para o tratamento da hepatite c BRPI0507747A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0403708A GB2411114B (en) 2004-02-19 2004-02-19 A botanical drug or dietary supplement
PCT/GB2005/000559 WO2005079823A1 (en) 2004-02-19 2005-02-17 Plant-based medicament for the treatment of hepatitis c

Publications (1)

Publication Number Publication Date
BRPI0507747A true BRPI0507747A (pt) 2007-07-10

Family

ID=32040026

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0507747-8A BRPI0507747A (pt) 2004-02-19 2005-02-17 medicamento com base em planta para o tratamento da hepatite c

Country Status (15)

Country Link
US (1) US7422760B2 (pt)
EP (1) EP1732578B1 (pt)
JP (1) JP2007523144A (pt)
KR (1) KR20070026422A (pt)
CN (1) CN1925864B (pt)
AT (1) ATE430574T1 (pt)
AU (1) AU2005215225A1 (pt)
BR (1) BRPI0507747A (pt)
CA (1) CA2555235C (pt)
DE (1) DE602005014348D1 (pt)
EA (1) EA014234B1 (pt)
ES (1) ES2327052T3 (pt)
GB (1) GB2411114B (pt)
MX (1) MXPA06009232A (pt)
WO (1) WO2005079823A1 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0500020D0 (en) 2005-01-04 2005-02-09 Novartis Ag Organic compounds
GB2411114B (en) 2004-02-19 2006-08-16 Phynova Ltd A botanical drug or dietary supplement
US8197860B2 (en) * 2005-06-23 2012-06-12 Nuliv Holding Inc. Method for enhancing nutrient absorption with astragalosides
CN1919204B (zh) * 2005-06-23 2011-07-27 维京仲华（上海）生物医药科技有限公司 利用人参皂苷调节营养物质吸收之方法
GB2428974B (en) * 2005-08-12 2010-02-03 Phynova Ltd Further medical use of a botanical drug or dietary supplement
GB0600134D0 (en) 2006-01-05 2006-02-15 Vernique Biotech Ltd Use of epoxidised molecules
GB2439046B (en) 2006-06-16 2010-12-08 Phynova Ltd Antiviral product
CN101078712A (zh) 2007-04-27 2007-11-28 上海现代中医药技术发展有限公司 扶正化瘀植物药血浆丹参素和丹酚酸b的测定方法
CN101334386B (zh) 2007-04-27 2012-07-11 上海现代中医药股份有限公司 扶正化淤植物药血浆苦杏仁苷的测定方法
CN101042380A (zh) * 2007-04-27 2007-09-26 上海现代中医药技术发展有限公司 扶正化淤植物药血浆五味子乙素的测定方法
CN101045092A (zh) 2007-04-29 2007-10-03 上海现代中医药技术发展有限公司 一种扶正化瘀植物药组合物的应用
CN101968465B (zh) * 2009-07-28 2013-07-17 秦引林 一种丹参酮ⅱa丙烯酸盐的液相色谱分析方法
US20110038915A1 (en) * 2009-08-14 2011-02-17 Eduardo Jose Gonzalez Chewing Gum Formula for Enhancing Psycho-Spirituality
US20120213870A1 (en) * 2011-02-17 2012-08-23 Maher El-Aaser Composition and method for treating liver disease
CN102696481A (zh) * 2012-05-15 2012-10-03 复旦大学 一种提高丹参毛状根中丹参酮类活性成分产量的方法
CN103901154B (zh) * 2014-03-28 2016-01-20 成都九芝堂金鼎药业有限公司 一种治疗糖尿病的中药制剂的薄层鉴别方法
CN103940943B (zh) * 2014-04-03 2016-01-20 王志敏 一种败酱草药材的鉴别方法
CN105287856A (zh) * 2015-11-25 2016-02-03 史克勇 护肝药物
CN105403654B (zh) * 2015-12-11 2017-04-05 陇西保和堂药业有限责任公司 一种提高黄芪薄层色谱鉴定的方法
US20200188466A1 (en) * 2017-04-25 2020-06-18 Reyoung Corporation Compositions of schisandra extracts and methods thereof
RU2654709C1 (ru) * 2017-04-26 2018-05-22 Федеральное государственное бюджетное образовательное учреждение высшего образования "Смоленский государственный медицинский университет" министерства здравоохранения Российской Федерации Противовоспалительное средство
CN109444319B (zh) * 2018-10-25 2020-10-02 吕梁学院 一种测定北芪菇中黄芪苷含量的方法
CN118838282B (zh) * 2024-06-28 2025-03-28 宜宾市博汇生物科技有限公司 一种植物药物制备生产控制方法、系统及存储介质

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1071581A (zh) 1991-10-19 1993-05-05 孙明君 速效肝炎灵的配制方法
AUPN411195A0 (en) * 1995-07-10 1995-08-03 Cathay Herbal Laboratories Pty Ltd Medicinal composition
CN1053825C (zh) 1995-09-15 2000-06-28 李永光 五苓丙肝散
CN1053375C (zh) * 1996-05-27 2000-06-14 刘智华 一种治疗肝病的中药制剂
CN1151312A (zh) 1996-07-14 1997-06-11 江洋 丙肝胶囊及其制备方法
CN1183288A (zh) * 1996-11-23 1998-06-03 邹长青 乙艾丸(散)及其制造方法
US6043276A (en) * 1998-06-25 2000-03-28 Georgetown University School Of Medicine Compounds obtained from salvia species having antiviral activity
JP2001039868A (ja) * 1999-07-30 2001-02-13 Soutetsu Cho 抗ウイルス製剤および該製剤を用いたウイルス感染症予防・治療方法
US6455078B1 (en) * 2000-10-18 2002-09-24 Tzu-Sheng Wu Medicinal herbal composition for treating liver diseases and HIV
US20020102237A1 (en) * 2000-11-13 2002-08-01 Milton Hammerly Compositions and methods for hepatitis treatment
CN1393255A (zh) 2001-06-25 2003-01-29 刘玉璋 丙肝病毒清
CN1371713A (zh) 2002-03-25 2002-10-02 刘振顺 一粒丹
CN100348199C (zh) * 2002-12-19 2007-11-14 王登之 治疗肝炎的水飞蓟宾葡甲胺分散片及其制备方法
DE60315732T2 (de) 2003-06-30 2008-06-05 Pirelli Tyre S.P.A. Verfahren zur herstellung von gummibestandteilen für luftreifen
GB2411114B (en) 2004-02-19 2006-08-16 Phynova Ltd A botanical drug or dietary supplement

Also Published As

Publication number Publication date
EA014234B1 (ru) 2010-10-29
GB2411114A (en) 2005-08-24
GB0403708D0 (en) 2004-03-24
HK1098959A1 (en) 2007-08-03
EA200601523A1 (ru) 2007-02-27
WO2005079823A1 (en) 2005-09-01
CA2555235A1 (en) 2005-09-01
KR20070026422A (ko) 2007-03-08
EP1732578A1 (en) 2006-12-20
EP1732578B1 (en) 2009-05-06
US20070160693A1 (en) 2007-07-12
GB2411114B (en) 2006-08-16
JP2007523144A (ja) 2007-08-16
ATE430574T1 (de) 2009-05-15
US7422760B2 (en) 2008-09-09
DE602005014348D1 (de) 2009-06-18
ES2327052T3 (es) 2009-10-23
CN1925864A (zh) 2007-03-07
MXPA06009232A (es) 2007-01-26
CA2555235C (en) 2013-10-15
AU2005215225A1 (en) 2005-09-01
CN1925864B (zh) 2011-07-06

Similar Documents

Publication Publication Date Title
BRPI0507747A (pt) medicamento com base em planta para o tratamento da hepatite c
Alam et al. Traditional herbal medicines, bioactive metabolites, and plant products against COVID-19: update on clinical trials and mechanism of actions
Li et al. The signaling pathways and targets of natural compounds from traditional Chinese medicine in treating ischemic stroke
Tao et al. Shufeng Jiedu Capsule protect against acute lung injury by suppressing the MAPK/NF-κB pathway
WO2007020382A3 (en) Plant-based medicament for the treatment of liver disease
Ki et al. Natural compounds for preventing age-related diseases and cancers
Li et al. Current perspective of traditional Chinese medicines and active ingredients in the therapy of hepatocellular carcinoma
Choe et al. The efficacy of traditional medicinal plants in modulating the main protease of SARS‐CoV‐2 and cytokine storm
Mullin et al. Dietary supplements for COVID-19
Arzi et al. Countering triple negative breast cancer via impeding Wnt/β-catenin signaling, a phytotherapeutic approach
Bleakney Deconstructing an adaptogen: Eleutherococcus senticosus
Chen et al. Tong Xie Yao Fang: A classic Chinese medicine prescription with potential for the treatment of ulcerative colitis
Luo et al. Clinical evidence and mechanisms of traditional Chinese medicine in major diseases
Hazra et al. Safety issues of herb-warfarin interactions
Yao et al. Exploring the role of traditional Chinese medicine in sarcopenia: mechanisms and therapeutic advances
Pillai et al. Harnessing the immunomodulatory potential of natural products in precision medicine—a comprehensive review
Dippenaar Herbal and alternative medicine: the impact on anesthesia
Ohkura et al. Screening for hemostatic activities of popular Chinese medicinal herbs in vitro
Bagwe et al. Herbal approach in the treatment of pancytopenia
Van Giang et al. Traditional Vietnamese Medicine Containing Garlic Extract for Patients With Non-severe COVID-19: A Phase-II, Double-Blind, Randomized Controlled Trial
Williams-Orlando Human immunodeficiency virus and herbal medicine
BRPI0516545A (pt) uso de óleo de lavanda para a profilaxia e tratamento de neurastenia, distúrbios de somatização e outras doenças associadas ao estresse
Nathan et al. Impact of nutraceuticals on immunomodulation against viral infections—A review during COVID‐19 pandemic in Indian scenario
Risto et al. Alternative therapies for viral infections caused by SARS-Cov-2
WO2022015275A1 (en) Herbal composition that provides protection against viruses and has medicinal and pharmacological properties

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61K 35/78 , A61P 31/20

Ipc: A61K 36/28 (2006.01), A61K 36/481 (2006.01), A61K

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]